QIAGEN
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.About QGEN
QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.
QGEN Key Statistics
Stock Snapshot
The current QIAGEN(QGEN) stock price is $55.62, with a market capitalization of 11.5B. The stock trades at a price-to-earnings (P/E) ratio of 27.80 and offers a dividend yield of 48.5%.
As of 2026-01-23, QIAGEN(QGEN) stock has fluctuated between $53.38 and $55.65. The current price stands at $55.62, placing the stock +4.2% above today's low and -0.0% off the high.
The QIAGEN(QGEN)'s current trading volume is 4.31M, compared to an average daily volume of 4.17M.
In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $37.63.
In the last year, QIAGEN(QGEN) shares hit a 52-week high of $57.82 and a 52-week low of $37.63.
QGEN News
Claim 50% Off TipRanks Premium An update from Qiagen ( (QGEN) ) is now available. Qiagen disclosed that the Dutch Financial Markets Authority (AFM) has publis...
Deutsche Bank downgraded Qiagen (QGEN) to Hold from Buy with a price target of $54, up from $52. The firm says the shares have rallied on renewed takeover headl...
Advertisement Recent share performance and what it might signal Qiagen (QGEN) has quietly put together a steady run, with the stock showing positive returns o...
Analyst ratings
67%
of 24 ratingsMore QGEN News
Shareholders of Qiagen NV (Symbol: QGEN) looking to boost their income beyond the stock's 0.5% annualized dividend yield can sell the May covered call at the $6...
German life sciences tools company Qiagen N.V. (NYSE:QGEN) is reportedly reviewing strategic options, including a potential sale, as renewed takeover interest e...
Nephron Research downgraded Qiagen (QGEN) to Hold from Buy with a $59 price target Published first on TheFly – the ultimate source for real-time, market-moving...
In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $55.01, changing hands for $56.47/share. W...
Qiagen QGEN shares soared 16.6% in the last trading session to close at $55.45. The move was backed by solid volume with far more shares changing hands than in...
Patrick B Donnelly, an analyst from Citi, maintained the Hold rating on Qiagen. The associated price target is €44.84. Claim 50% Off TipRanks Premium Unlock hed...
Qiagen (QGEN) shares jumped 4% and were halted for volatility after Bloomberg’s Eyk Henning, Dinesh Nair, David Carnevali and Michelle Davis reported that the E...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.